Mariela Corrales1,2, Steeve Doizi1,2, Yazeed Barghouthy1,2, Hatem Kamkoum1,2, Bhaskar Somani3, Olivier Traxer4,5. 1. GRC Urolithiasis no. 20, Tenon Hospital, Sorbonne University, 75020, Paris, France. 2. Department of Urology AP-HP, Tenon Hospital, Sorbonne University, 75020, Paris, France. 3. University Hospital Southampton NHS Trust, Southampton, UK. 4. GRC Urolithiasis no. 20, Tenon Hospital, Sorbonne University, 75020, Paris, France. olivier.traxer@aphp.fr. 5. Department of Urology AP-HP, Tenon Hospital, Sorbonne University, 75020, Paris, France. olivier.traxer@aphp.fr.
Abstract
OBJECTIVE: To define which long-term stent would work best in malignant ureteral obstruction (MUO) and benign ureteral obstruction (BUO), focusing on their mechanisms of action, price and insertion approach. METHODS: A systematic review was developed using the MEDLINE and Scopus databases and in accordance with the PRISMA checklist. There were no language restrictions for the search. Studies describing the use of metallic ureteric stents for MUO and for BUO in humans were included. RESULTS: We analyzed five types of metallic stents (35 papers) and also the experience with the tumor and extra-anatomical stents. The Resonance, Memokath and Allium ureteral stents were found to be useful in BUO and MUO. The Uventa stent performed well in chronic ureteral obstruction. The Detour bypass stent was a recommended option in those patients who had complete obstruction of the ureter and were unfit for reconstructive surgery. There was no difference with regard to the insertion technique and both antegrade and retrograde approaches were equally successful. Although tumor stents showed a good performance, there were very few published studies on it. CONCLUSION: Metallic stents are a suitable option for MUO and BUO. When compared to standard double J stents, although they are relatively high priced, they show a financial benefit in the long-term. The Detour bypass stent seems to be an effective alternative for complete ureteral obstruction or patients unfit for surgery. Further prospective randomized studies should be done on the effectiveness of tumor stents versus metallic stents.
OBJECTIVE: To define which long-term stent would work best in malignant ureteral obstruction (MUO) and benign ureteral obstruction (BUO), focusing on their mechanisms of action, price and insertion approach. METHODS: A systematic review was developed using the MEDLINE and Scopus databases and in accordance with the PRISMA checklist. There were no language restrictions for the search. Studies describing the use of metallic ureteric stents for MUO and for BUO in humans were included. RESULTS: We analyzed five types of metallic stents (35 papers) and also the experience with the tumor and extra-anatomical stents. The Resonance, Memokath and Allium ureteral stents were found to be useful in BUO and MUO. The Uventa stent performed well in chronic ureteral obstruction. The Detour bypass stent was a recommended option in those patients who had complete obstruction of the ureter and were unfit for reconstructive surgery. There was no difference with regard to the insertion technique and both antegrade and retrograde approaches were equally successful. Although tumor stents showed a good performance, there were very few published studies on it. CONCLUSION: Metallic stents are a suitable option for MUO and BUO. When compared to standard double J stents, although they are relatively high priced, they show a financial benefit in the long-term. The Detour bypass stent seems to be an effective alternative for complete ureteral obstruction or patients unfit for surgery. Further prospective randomized studies should be done on the effectiveness of tumor stents versus metallic stents.
Authors: Achal P Modi; Chad R Ritch; David Arend; Rhonda M Walsh; Maria Ordonez; Jaime Landman; Mantu Gupta; Bodo E Knudsen Journal: J Endourol Date: 2010-07 Impact factor: 2.942
Authors: Udo Nagele; Markus A Kuczyk; Marcus Horstmann; Jörg Hennenlotter; Karl-Dietrich Sievert; David Schilling; Ute Walcher; Arnulf Stenzl; Aristotelis G Anastasiadis Journal: World J Urol Date: 2008-03-07 Impact factor: 4.226
Authors: James A Kuzman; David D Stenehjem; Joseph Merriman; Archana M Agarwal; Shiven B Patel; Andrew W Hahn; Anitha Alex; Dan Albertson; David M Gill; Neeraj Agarwal Journal: BMC Urol Date: 2017-01-05 Impact factor: 2.264
Authors: Min Seok Kim; Won Sik Jang; Doo Yong Chung; Dong Hoon Koh; Jong Soo Lee; Hyeok Jun Goh; Young Deuk Choi Journal: BMC Urol Date: 2019-01-03 Impact factor: 2.264